Salomon & Ludwin’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.26K Sell
15
-33
-69% -$8.68K ﹤0.01% 1858
2026
Q1
$13.1K Hold
48
﹤0.01% 1373
2025
Q4
$12.2K Buy
48
+33
+220% +$8.76K ﹤0.01% 1314
2025
Q3
$4.15K Buy
+15
New +$4.02K ﹤0.01% 1801
2024
Q4
Sell
-120
Closed -$26.8K 738
2024
Q3
$26.8K Hold
120
﹤0.01% 325
2024
Q2
$24.4K Hold
120
﹤0.01% 334
2024
Q1
$26.2K Hold
120
﹤0.01% 442
2023
Q4
$24.1K Hold
120
﹤0.01% 392
2023
Q3
$24.1K Buy
+120
New +$25.3K ﹤0.01% 392
2019
Q2
Sell
-3
Closed 244
2019
Q1
$0 Buy
+3
New +$370 ﹤0.01% 255

Other funds holding LH

Salomon & Ludwin's LH Position: Q2 2026 in Review

Salomon & Ludwin reduced its Labcorp (LH) stake by 69% in Q2 2026, selling an estimated $8.68K and leaving 15 shares worth $4.26K. The position accounts for ﹤0.01% of the portfolio, ranked #1858.

Salomon & Ludwin first reported a position in LH in Q1 2019 and has held it in 10 quarters since. The position peaked at $26.8K in Q3 2024. 1,059 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Salomon & Ludwin held 15 shares of Labcorp worth $4.26K as of Q2 2026.
  • Salomon & Ludwin sold 33 Labcorp shares in Q2 2026, an estimated $8.68K.
  • Labcorp made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #1858 holding.
  • Salomon & Ludwin first reported a position in Labcorp in Q1 2019 and has held it in 10 quarters since.
  • Salomon & Ludwin's Labcorp position peaked at $26.8K in Q3 2024.
  • 1,059 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.